drugset / Trial / NCT06812637
Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
Study effeciency and safety of WJ-MSC derived exosomes in DFU healing
Timeline
- Start
- 2024-04-06
- Primary completion
- 2024-06-06
- Completion
- 2024-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WJ-MSC- Exosomes | Other / unclassified | — | Topical |